Cuijpers P. Targets and outcomes of psychotherapies for mental disorders: An overview. World Psychiatry. 2019;18:276.
Herzog P, Lauff S, Rief W, Brakemeier EL. Assessing the unwanted: A systematic review of instruments used to assess negative effects of psychotherapy. Brain Behav. 2019;9.
Wiebe A, Kannen K, Selaskowski B, Mehren A, Thöne AK, Pramme L, et al. Virtual reality in the diagnostic and therapy for mental disorders: A systematic review. Clin Psychol Rev. 2022;98.
Klatte R, Strauss B, Flückiger C, Rosendahl J. Adverse effects of psychotherapy: Protocol for a systematic review and meta-analysis. Syst Rev. 2018;7.
Schneider SC, Knott L, Cepeda SL, Hana LM, McIngvale E, Goodman WK, et al. Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences. Depress Anxiety. 2020;37:418–28.
Barnard D. History of VR—Timeline of events and tech. development. 2023.
Carl E, Stein AT, Levihn-Coon A, Pogue JR, Rothbaum B, Emmelkamp P, et al. Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials. J Anxiety Disord. 2019;61:27–36.
Cullen AJ, Dowling NL, Segrave R, Carter A, Yücel M. Exposure therapy in a virtual environment: Validation in obsessive compulsive disorder. J Anxiety Disord. 2021;80:102404.
Javaherirenani R, Mortazavi SS, Shalbafan M, Ashouri A, Farani AR. Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: A randomized clinical controlled trial. Bmc Psychiatry. 2022;22:740.
Article PubMed PubMed Central Google Scholar
Scott J. The science and practice of psychotherapy: the critical need for quality assurance and vigilance to monitor the ratio of benefits to risks of therapies. Acta Psychiatr Scand. 2017;136:233–5.
Olatunji BO, Deacon BJ, Cruelest Cure AJST. Issues in the implementation of exposure-based treatments. Ethical. 2009.
McKay D, Abramowitz JS, Storch EA. Mechanisms of harmful treatments for obsessive-compulsive disorder. Clinical Psychology. and Practice: Science; 2020.
Moritz S, Fieker M, Hottenrott B, Seeralan T, Cludius B, Kolbeck K, et al. No pain, no gain? Adverse effects of psychotherapy in obsessive-compulsive disorder and its relationship to treatment gains. J Obsessive Compuls Relat Disord. 2015;20155:61–6.
Ladwig I, Rief W, Nestoriuc Y. What are the risks and side effects of psychotherapy? – Development of an inventory for the assessment of negative effects of psychotherapy (INEP). Verhaltenstherapie. 2014;24:252–63.
Hendriks L, de Kleine RA, Broekman TG, Hendriks GJ, van Minnen A. Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma and multiple treatment attempts. Eur J Psychotraumatol. 2018;9.
Jacobson, N. S., Truax, P. (1991). Clinical Significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol, 59.
Rolvien L, Lohse L, Borgmann L, Moritz S, Kühn S, Jelinek L, et al. Exposure and response prevention in virtual reality for obsessive-compulsive disorder: a randomized controlled trial. (submitted).
Jelinek L, Peth J, Runde A, Arlt S, Scheunemann J, Gallinat J. Metacognitive Training for Depression: Feasibility, safety and acceptability of two new treatment modules to reduce suicidality. Clin Psychol Psychother. 2020;28:669–81.
Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG. Simulator sickness questionnaire: An enhanced method of quantifying simulator sickness. Int J Aviat Psychol. 1993;3:203–20.
Bouchard S, Berthiaume M, Robillard G, Forget H, Daudelin-Peltier C, Renaud P, et al. Arguing in favor of revising the simulator sickness questionnaire factor structure when assessing side effects induced by immersions in virtual reality. Front Psychiatry. 1926; 2021.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. Arch Gen Psychiatry. 1989;46:1006–11.
Article CAS PubMed Google Scholar
Hand I, Büttner-Westphal H. Die Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Ein halbstrukturiertes Interview zur Beurteilung des Schweregrades von Denk- und Handlungszwängen. Verhaltenstherapie. 1991;1:223–5.
Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. In A. E. Kazdin (Ed.), Methodological Issues & Strategies in Clinical Research. 2004:631–648.
Patterson B, Boyle MH, Kivlenieks M, Van Ameringen M. The use of waitlists as control conditions in anxiety disorders research. J Psychiatr Res. 2016;83:112–20.
Craske MG, Kircanski K, Zelikowsky M, Mystkowski J, Chowdhury N, Baker A. Optimizing inhibitory learning during exposure therapy. Behav Res Ther. 2008;46:5–27.
Keijsers GP, Hoogduin CAL, Schaap CPDR. Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br J Psychiatry. 1994;165:781–6.
Article CAS PubMed Google Scholar
Merling LF, Siev J, Delucia C, Davidtz J. I think I can: The role of self-efficacy in exposure to contamination. J Soc Clin Psychol. 2022;41(5):423–43.
Himle JA, Van Etten ML, Janeck AS, Fischer DJ. Insight as a predictor of treatment outcome in behavioral group treatment for obsessive-compulsive disorder. Cognit Ther Res. 2006;30:661–6.
Gan J, He J, Fu H, Zhu X. Association between obsession, compulsion, depression and insight in obsessive-compulsive disorder: a meta-analysis. Nord J Psychiatry. 2022;76:489–96.
Guidi J, Brakemeier EL, Bockting CLH, Cosci F, Cuijpers P, Jarrett RB, et al. Methodological recommendations for trials of psychological interventions. Psychother Psychosom. 2018;87:276–84.
Comments (0)